Back to Search
Start Over
Successful Early Lamotrigine and Aripiprazole Augmentation of Clomipramine in Severe Obsessive-compulsive Disorder.
- Source :
-
Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology [Clin Psychopharmacol Neurosci] 2023 Aug 31; Vol. 21 (3), pp. 604-608. - Publication Year :
- 2023
-
Abstract
- Lamotrigine and aripiprazole have shown efficacy as augmentation agents of serotonin reuptake inhibitors for treatment-resistant obsessive-compulsive disorder (OCD). To date, the efficacy of lamotrigine/aripiprazole augmentation has not been reported in OCD treatment. Herein, we report the case of a 37-year-old male with severe OCD and comorbid depression whose symptoms markedly improved after low-dose lamotrigine/aripiprazole augmentation to clomipramine. Our report suggests that early glutamatergic/antipsychotic augmentation contributes to rapid remission of OCD symptoms.
Details
- Language :
- English
- ISSN :
- 1738-1088
- Volume :
- 21
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology
- Publication Type :
- Report
- Accession number :
- 37424428
- Full Text :
- https://doi.org/10.9758/cpn.22.1044